Evidence map›Paper›PMID 35570890›Full record

SynthesisFrontiers in public health2022

Seroprevalence of Hepatitis B Among Healthcare Workers in Asia and Africa and Its Association With Their Knowledge and Awareness: A Systematic Review and Meta-Analysis.

Nur Hasnah Maamor, Nor Asiah Muhamad, Nor Soleha Mohd Dali, Mohd Hatta Abdul Mutalip, Fatin Norhasny Leman, Tahir Aris, Nai Ming Lai, Muhammad Radzi Abu Hassan

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nur Hasnah MaamorSector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Nor Asiah MuhamadSector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Nor Soleha Mohd DaliInstitute for Medical Research, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Mohd Hatta Abdul MutalipInstitute for Public Health, National Institute of Health, Ministry of Health, Setia Alam, Malaysia.
Fatin Norhasny LemanSector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Tahir ArisInstitute for Medical Research, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Nai Ming LaiSchool of Medicine, Taylor's University, Subang Jaya, Malaysia.
Muhammad Radzi Abu HassanDepartment of Medicine, Sultanah Bahiyah Hospital, Ministry of Health, Alor Setar, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The hepatitis B virus (HBV) is a blood-borne virus that can be transmitted by percutaneous and mucocutaneous contact with infected bodily fluid. Healthcare workers (HCWs) are more exposed to HBV infection. They must have a thorough understanding of HBV infection since they can contract and spread the virus. In this study, we systematically reviewed all published evidence on the seroprevalence of Hepatitis B virus (HBV) infection among HCWs. and synthesize evidence on the association between knowledge and awareness with HBV infection. Methods: We searched PubMed, EMBASE, Cochrane Library and Scopus for studies reporting on HBV seroprevalence from January 1997 to September 2021 among healthcare workers. We used random-effects meta-analyses to estimate the pool prevalence of HBV infection. Results: We identified 25 studies that met our inclusion criteria, with data on 10,043 adults from 11 countries and two regions: Africa and Asia. The overall seroprevalence of HBV was 5.0% (95% confidence interval [CI] 3.6%), with Africa reporting higher estimates (5.0%, 95% CI 3.7%) than Asia population (4.0%, 95% CI 1.9%). The highest pooled prevalence estimate in African countries came from studies published in the Cameroon region (8.0%, 95% CI 5-10%) while the lowest came from Ethiopia (4.0%, 95% CI 2.6%). The overall seroprevalence estimates in the African population were significantly higher than those in the Asian group. Studies in Africa found that the average knowledge and seroprevalence were 1.4% and 11.0%, respectively where, eight studies (53.3%) reported good knowledge and seven studies (46.7%) reported average knowledge. In Asia, two studies (40.0%) reported good knowledge, one study (20.0%) reporting average knowledge, and two studies (40.0%) reporting poor knowledge. African studies demonstrated good knowledge despite the fact that their HBV infection rate was higher than 6.7%. Conclusion: Africa and Asia have the highest seroprevalence of HBV infection. Improving the comparability of epidemiological and clinical studies constitutes an important step forward. More high-quality data is needed to improve the precision of burden estimates. Systematic Review Registration: PROSPERO CRD42021279905.

Indexed as

Hepatitis BAdultCameroonHealth PersonnelHepatitis B virusHumansSeroepidemiologic Studiesawarenessepidemiologyhealthcare workershepatitis B virusinfectionknowledgeprevalenceseroprevalence

Identifiers

PMID35570890
PMCPMC9096243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.